BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18180618)

  • 1. Sole existence of antithrombin antibody in patients with systemic lupus erythematosus showing tendency of its antigenic determinants directing against exosite II (antithrombin/heparin binding site) of thrombin.
    Matsuda J; Matsuyama A; Atsumi G; Ohkura N
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):66-9. PubMed ID: 18180618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus.
    Ginsberg JS; Demers C; Brill-Edwards P; Bona R; Johnston M; Wong A; Denburg JA
    Am J Med; 1995 Apr; 98(4):379-83. PubMed ID: 7709951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free protein S deficiency may be found in patients with antiphospholipid antibodies who do not have systemic lupus erythematosus.
    Crowther MA; Johnston M; Weitz J; Ginsberg JS
    Thromb Haemost; 1996 Nov; 76(5):689-91. PubMed ID: 8950774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical performance of antibodies to prothrombin and thrombin in Chinese patients with antiphospholipid syndrome: potential interest in discriminating patients with thrombotic events and non-thrombotic events.
    Zhang S; Wu Z; Li J; Li P; Chen S; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
    Rheumatol Int; 2017 Apr; 37(4):579-584. PubMed ID: 27807637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation.
    Rahgozar S; Yang Q; Giannakopoulos B; Yan X; Miyakis S; Krilis SA
    Arthritis Rheum; 2007 Feb; 56(2):605-13. PubMed ID: 17265495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of antithrombin antibody in atherosclerosis patients negative for antiprothrombin antibody, anticardiolipin antibody and lupus anticoagulant.
    Matsuda J; Miebori T; Matsuyama A
    Thromb Res; 2007; 120(2):307-10. PubMed ID: 17055555
    [No Abstract]   [Full Text] [Related]  

  • 8. How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive.
    Giles I; Rahman A
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):525-37. PubMed ID: 19591782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous thrombin potential in the assessment of hypercoagulability in systemic lupus erythematosus.
    Mehta BM; Kiani AN; Chen C; Jani J; Kickler TS; Petri M
    Am J Hematol; 2010 Jan; 85(1):83-5. PubMed ID: 20029948
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation.
    Sakai Y; Atsumi T; Ieko M; Amengual O; Furukawa S; Furusaki A; Bohgaki M; Kataoka H; Horita T; Yasuda S; Koike T
    Arthritis Rheum; 2009 Aug; 60(8):2457-67. PubMed ID: 19644870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
    Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
    Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
    J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis.
    Alessandri C; Sorice M; Bombardieri M; Conigliaro P; Longo A; Garofalo T; Manganelli V; Conti F; Esposti MD; Valesini G
    Arthritis Res Ther; 2006; 8(6):R180. PubMed ID: 17150088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New approaches to characterizing the immune status of patients with lupus erythematosus using immunoenzyme testing].
    Glavinskaia TA; Rezaĭkina AV; Komarova VD
    Vestn Dermatol Venerol; 1990; (1):4-8. PubMed ID: 2327169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monoclonal antibodies against the complex of phosphatidylserine and prothrombin from patients with the antiphospholipid antibodies.
    Horita T; Ichikawa K; Kataoka H; Yasuda S; Atsumi T; Koike T
    Lupus; 2007; 16(7):509-16. PubMed ID: 17670850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane autoantibodies in systemic lupus erythematosus: a case of autoimmune hemolytic anemia, antiphospholipid antibodies, and transient acquired activated protein C resistance.
    Staropoli JF; Van Cott EM; Makar RS
    Transfusion; 2008 Nov; 48(11):2435-41. PubMed ID: 18673345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to FXa and thrombin in patients with SLE differentially regulate C3 and C5 cleavage.
    McDonnell T; Amarnani R; Spicer C; Jbari H; Pericleous C; Spiteri VA; Wincup C; Artim-Esen B; Mackie I; Botto M; Rahman A; Giles I
    Lupus Sci Med; 2022 Aug; 9(1):. PubMed ID: 36007979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified phosphatidylserine-dependent antiprothrombin [corrected] ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies.
    Žigon P; Ambrožič A; Čučnik S; Kveder T; Rozman B; Božič B
    Clin Chem Lab Med; 2011 Jun; 49(6):1011-8. PubMed ID: 21574879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological and clinical relevance of anti-prothrombin antibodies.
    Ghirardello A; Bizzaro N; Zampieri S; Iaccarino L; Bassi N; Tozzoli R; Ruffatti A; Villalta D; Tonutti E; Doria A
    Ann N Y Acad Sci; 2007 Aug; 1109():503-10. PubMed ID: 17785339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.